Acasă › Leucemie mieloasă acută › Missouri › Kansas City
Studii clinice pentru Leucemie mieloasă acută în Kansas City, MO
15 studii pentru Leucemie mieloasă acută caută participanți în și în jurul orașului Kansas City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
În curs de recrutareFaza 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- și încă 1
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Kansas City Veterans Affairs Medical Center, Kansas City
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · La 5 mi distanță
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · La 5 mi distanță
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · La 5 mi distanță
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · La 5 mi distanță
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
În curs de recrutareFaza 3
- Children's Mercy Hospitals and Clinics, Kansas City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
În curs de recrutareFaza 1/2
- Children's Mercy Hospitals and Clinics, Kansas City
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
În curs de recrutareFaza 1
- University of Kansas Hospital-Westwood Cancer Center, Westwood · La 5 mi distanță
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 3
- The Children's Mercy Hospital - Adele Hall Campus, Kansas City
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
În curs de recrutareFaza 1
- Children's Mercy Hospital of Kansas City, Kansas City
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
În curs de recrutareFaza 3
- University of Kansas Cancer Center, Westwood · La 5 mi distanță
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
În curs de recrutareStudiu observațional
- Children's Mercy Hospital and Clinics, Kansas City
- University of Kansas, Westwood · La 5 mi distanță
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
În curs de recrutareFaza 1
- University of Kansas Cancer Center, Westwood · La 5 mi distanță
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
În curs de recrutareFaza 2
- University of Kansas Medical Center, Westwood · La 5 mi distanță
Studii pentru Leucemie mieloasă acută în alte orașe
- Houston, TX85 studii
- New York City, NY51 studii
- Boston, MA44 studii
- Seattle, WA41 studii
- Baldwin Park, CA40 studii
- Columbus, OH35 studii
- Philadelphia, PA34 studii
- Durham, NC33 studii
- Atlanta, GA31 studii
- Tampa, FL29 studii
- Chicago, IL26 studii
- Portland, OR25 studii
Alte studii în Kansas City
- Cancer de sân34 studii
- Cancer pulmonar cu celule non-pătrate31 studii
- Insuficiență cardiacă25 studii
- Cancer (toate tipurile)21 studii
- Cancer pulmonar19 studii
- Cancer colorectal16 studii
- Cancer metastatic15 studii
- Cancer de prostată14 studii
- Cancer ovarian11 studii
- Obezitate11 studii
- Diabet de tip 211 studii
- Boli cardiovasculare11 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.